Australian (ASX) Stock Market Forum

ENL - Enlitic Inc.

Jump to new
Dona Ferentes

Dona Ferentes

A little bit OC⚡DC
Joined
11 January 2016
Posts
15,069
Reactions
20,437
U.S. based, listing on ASX.

Listing date18 December 2023 #
Company contacthttps://enlitic.com/
Ph: 1 970 657 9218
Principal ActivitiesEnlitic is an information technology and services company that harnesses the power of artificial intelligence to manage medical imaging data in radiology (such as MRI, CT, X-ray and ultrasound images).
Issue PriceAUD 0.83
Issue TypeChess Depositary Interests 1:1
Security codeENL
Capital to be Raised$35,000,000
Expected offer close date05 December 2023
UnderwriterMST Financial Services Pty Ltd (Underwriter and Lead Manager).
 
gee, there are a lot of software/ AI/ imaging outfits around.
.

Our Healthcare Data Solutions​

ENDEX™ is a medical imaging solution that standardizes your data and improves workflows, helping to make your radiology department more efficient and reduce mundane tasks. By using computer vision and natural language processing, ENDEX maps DICOM and metadata to consistent and standardized study descriptions enabling consistent hanging protocol displays, accurate data routing, improved billing capabilities and administrative staff can reclaim time from fixing hanging protocols or searching for studies. ENDEX also enriches your data for research or monetization strategies, and with data that is standardized and clinically relevant, data analysis becomes much easier. ENDEX™ provides a comprehensive solution to your radiology department’s data governance issues, allowing for more efficient workflows, improved data quality, and enhanced value for research or monetization.

ENCOG™ is an intelligent solution designed to de-identify medical imaging data while retaining clinically relevant information, saving you time and resources. Traditional anonymization tools delete data indiscriminately, leading to poor quality data and loss of important information. ENCOG uses AI to detect and protect PHI while preserving clinical relevance, enabling data to be used for research and analysis. It supports multiple modalities, including CT, MR, US, and XR, and can be used for rounds/teaching files, clinical trials, training algorithms/validation testing, national disease registries, and real-world evidence databases. With ENCOG you can confidently protect your patients’ PHI and maintain high-quality data for better decision-making.
 
Maybe its a thing , Next to nothing EV so any hint of a positive ann will move significant
 
Chipp said:
Maybe its a thing , Next to nothing EV so any hint of a positive ann will move significant
Click to expand...
or less than a hint ... up on no news... leading July comp right now; what's going on, @Chipp ?
.
Screenshot_20240718-131451_CommSec.jpg

.
low volume too
 
Medical imaging software business Enlitic, which has shrunk from $70 million-plus to just $7 million market capitalisation in the nine months since its listing, is looking for $20 million to fund an acquisition and working capital break-even.

Fund managers were told Enlitic would spend $US4.95 million ($7.3 million) to acquire Laitek, a provider of healthcare medical imaging data migration and routing services in the US. The business posted $US6.8 million revenue in the 2023 financial year, and would bring combined group revenue to $US8.3 million to $US9.6 million this calendar year.

The $7.3 million payment is split as $5.9 million cash and $1.4 million worth of shares. MST Financial advised on the acquisition and is acting as a joint lead manager on the raise alongside Taylor Collison.

The brokers’ pitch to potential investors said the acquisition would add significant data to Enlitic’s AI models, move critical technology in-house, and expand market reach. Enlitic has gone from one channel partner to 17 since June 2023 but was stung by a difficult market and low volumes, it added.

Enlitic’s substantial shareholders include Thorney Technologies, Regal, Marubeni Corporation and the Liberman family. It was floated at 83¢ per CDI in December, and was down to 9¢ at Wednesday’s close.
 
now 6.7c

had an insto "pass the hat around " in Sept. Some significant holders dropped off, new one on board. Raised $22.4M

Thursday, 29 August 2024 : signed a binding conditional agreement to acquire US medical imaging data migration company, Laitek Inc., for a total consideration of US$4.95M (c.A$7.3M) consisting of:
• cash payment of US$4M (c.A$5.9M); and
• common stock of the Company to the value of US$950,000 (c.A$1.4M) subject to obtaining securityholder approval for the purposes of ASX Listing Rule 7.1..

now SPP for a mill or so more:

SPP will open Thursday, 17 October 2024, to eligible Enlitic CDI holders, who had a registered address in Australia or New Zealand on Enlitic’s register at Friday, 30 August 2024 to apply for up to $30,000 of New CDIs free of any brokerage, commission and transaction costs. Participation in the SPP is optional.

The New CDIs will be offered at an issue price of $0.05, being the same issue price as the Conditional Placement.

Proceeds from the SPP will be used for general corporate and working capital purposes and flexibility in implementing Enlitic’s strategic commercial objectives as outlined.
 
Top